$MRK Phase 1|Phase 2 Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow Lymphoblasts…NCT03160079. Estimated Primary Completion Date -  08/2020